Cardiomyopathy & Transplantation | Heart Rhythm Services | Preventive Cardiology & Vascular Biology | Hypertension | Cardiovascular Imaging | Cardiac Catheterization & Intervention | Cardiovascular Research & Basic Science
Dr. Stephen Gottlieb's investigations center on the physiology of congestive heart failure. This has included a particular interest in neurohormonal activation and renal function in CHF patients. Dr. Gottlieb was United States principal investigator for MERIT and was co-chairman of the mortality committee of BEST. Dr. Gottlieb is particularly interested in the interaction of heart failure and renal dysfunction, having studied the impact of adenosine antagonists and other medications and interventions on renal function and the physiology of renal function in heart failure patients. He has published about the interaction of depression and heart failure, and he has investigated the effects of home telemonitoring, sleep abnormalities and genetic polymorphisms in heart failure patients.
Dr. Erika Feller is an assistant professor and the medical director of Cardiac Transplantation at the University of Maryland. Prior to coming to the University of Maryland in the fall of 2004, Dr. Feller had spent five years at Temple University Hospital, where she was a medical intern, medical resident, cardiology fellow and chief cardiology fellow. Her areas of special interest include heart failure, heart transplant immunology and left ventricular assist device physiology.
Dr. Shawn W. Robinson is an assistant professor of medicine and physiology and the medical director of our CCU. He received Internal Medicine training at the University of Maryland Medical Center, and completed a fellowship in Cardiovascular Diseases at The Johns Hopkins Hospital. Dr. Robinson's clinical focus is congestive heart failure and cardiac critical care. His research in the area of pharmacogenomics investigates how various genetic polymorphisms may influence cardiac function and treatment. Through collaborative efforts he is helping to build a genetic database of patients with heart disease being treated at the medical center.
Dr. Myung Park established and heads our Pulmonary Arterial Hypertension Program, and currently cares for over 500 patients with this disorder. Dr. Park has published extensively regarding his experience, and is involved in trials of inhaled iloprost, sitaxsentan and several studies of combination therapy for PAH. Additionally, she is studying the role of TGF-beta in this condition, as well as the impact of affective disorders on outcomes in PAH patients. Dr. Park also works closely with our cardiothoracic surgeons as part of a multidisciplinary team caring for pulmonary thromboendarterectomy and transplant patients.
Dr. Ramani is an Assistant Professor of Medicine. He received his medical degree from Jefferson Medical College and completed an internal medicine residency at the University of Pittsburgh, where he also completed a cardiovascular diseases fellowship. Dr. Ramani's special interests include congestive heart failure, transplantation, and pulmonary arterial hypertension. Dr. Ramani also participates in the performance of transesophageal echo and interpretation of all echo studies, as well as participating in cath lab hemodynamic studies.
Dr. Patricia Uber is an Assistant Professor of Medicine. She has authored over 100 publications, including 60 peer-reviewed original research papers, investigating new immunosuppressant regimens in heart transplantation, genetic approaches to personalized medicine, health care disparities in African-American heart transplant recipients and biomarkers in obese patients with heart failure. She regularly serves on the scientific program committees for the Heart Failure Society of America and the International Society of Heart and Lung Transplantation. She participates daily in the care of heart failure and transplant patients on our CCS service.
Dr. Stephen Shorofsky is a Professor of Medicine and the Director of our program in Cardiac Electrophysiology. He received his medical degree, Ph.D., and EP training at the University of Chicago. His expertise is in management of arrhythmias using devices, drugs and catheter ablation techniques. In addition, he has a 14-year research background in cardiac cellular electrophysiology, including the use of high-resolution imaging techniques, to study mechanism of arrhythmias and heart failure. His research interests include defibrillation, mechanisms and treatment of arrhythmias, newer technology development, imaging for electrophysiology studies and cellular electrophysiology.
Dr. Timm Dickfeld received his M.D. and Ph.D. from the JW Goethe Medical School and completed training in Cardiovascular Disease and Electrophysiology at Johns Hopkins Hospital. Dr. Dickfeld's research interest involves novel imaging guidance for complex ablations. He has published extensively within this area, and has been recognized with a named award by the AHA for his contributions to the field. In addition to his work at the University of Maryland, he is the Chief of the EP section at the Baltimore VAMC.
Dr. Robert Hood served as Chief of Cardiology at the National Naval Medical Center in Bethesda before joining the faculty at the University of Maryland. He is board certified in IM, Cardiovascular Disease, and Electrophysiology. Dr. Hood is the Director of Outpatient Cardiac Services, organizes and runs our ECG conference, and participates in clinical cardiac electrophysiology, as well as fully participating in the operations of the echocardiography laboratory.
Dr. Robert Peters is a Professor of Medicine, and Chief of Cardiology at the Baltimore VAMC. His major interests include the chronobiology of cardiac arrhythmias, sudden cardiac death and acute myocardial infarction. He is the author of more than 250 articles, chapters and abstracts, and he serves as a reviewer for Circulation, the Journal of the American College of Cardiology, PACE, and Chest.
Dr. Robert Vogel is Professor of Medicine and the Director of Clinical Vascular Biology at the University of Maryland. He served as the Chief of the Division of Cardiology from 1986-2000. He has been a president of the Association of University Cardiologists and a recipient of a Federal Scientist of the Year award. His research has focused on the vascular biology of lipids and lifestyle. He is an author on more than 250 publications and a consultant to the NIH, NFL and Pritikin Longevity Center.
Dr. Michael Miller is an Associate Professor of Medicine and Epidemiology and Public Health. He is Director of the Center for Preventive Cardiology for the University of Maryland Medical System. His research interests include disorders of lipid and lipoprotein metabolism, molecular studies of HDL, triglycerides and the postprandial response to dietary fat, nontraditional coronary risk factors and clinical trials to reduce atherosclerosis. Dr. Miller has participated in landmark clinical trials including AVERT, MIRACL, PROVE-IT, TNT and COURAGE. Ongoing clinical trials include IMPROVE IT and Dal-Outcomes.
Dr. Elijah Saunders helped develop the national guidelines for the treatment of hypertension and is co-founder of the International Society on Hypertension in Blacks. A co-founder and past president of the Association of Black Cardiologists, Dr. Saunders's clinical and research interests are related to hypertension. They include coronary disease in black populations, community programs to increase hypertension control, cardiovascular complications secondary to hypertension and severe and difficult-to-control hypertension.
Dr. Wallace Johnson is a graduate of the University of Maryland School of Medicine, where he is a Clinical Assistant Professor. His clinical and research interests are in hypertension.
Dr. John Gottdiener is a Professor of Medicine and Director of Echocardiography. His recent research interests include the characterization of cardiovascular health and risk in the elderly through the use of The Cardiovascular Health Study. He has established our echo lab as a core lab for several ongoing national studies, and he has recently mentored fellows towards presentation of national abstracts and publication of manuscripts regarding dyssynchrony as well as the impact of asymptomatic LV dysfunction on incident heart failure and mortality.
Dr. Chris deFilippi is the Associate Director of our echo lab. His clinical duties include cardiac catheterization and endomyocardial biopsy, performance and interpretation of TEE, including expertise in real-time 3-D acquisition, and attending on our PCS and Consult services. His research interests have focused on the role of cardiac biomarkers and cardiac health and disease in patients with chronic kidney disease.
Dr. Gary Plotnick's expertise is in the field of echocardiography. His research interests have included unstable angina, diastolic function, pericardial disease and most recently, endothelial function. He has authored or coauthored over 118 articles, 11 book chapters, 94 abstracts and 3 books. He has served on the board of directors of the American Society of Echocardiography. Dr. Plotnick has been very involved with medical school and graduate education. He has won numerous teaching awards including nine Golden Apple Awards, a campus-wide Founder's Day Teacher of the Year Award, the Alpha Omega Alpha Outstanding Faculty Member Award and the Theodore E. Woodward Outstanding Clinician-Educator Award from the American College of Physicians. Dr. Plotnick runs our weekly Clinical Conference and our weekly Echocardiography Conference.
Dr. Michael Benitez is the Director of the Fellowship Training Program and the Director of In-Patient Clinical Cardiology. He has twice been awarded the Department of Medicine's award for resident teaching, and in 2008 was awarded the W. Proctor Harvey Award for Education by the American College of Cardiology. He serves as the Editor-in- Chief for ACCIS, the ACC In-Service for Fellows, and is an editor for CardioSmart, an ACC direct-to-patient initiative. Formally trained in cardiac catheterization, he spends more time now in echocardiography and attending on the PCS service.
Dr. Scott Jerome currently serves as an Assistant Professor of Medicine and full-time faculty member at the University of Maryland School of Medicine. He participates in consultative cardiology at the University of Maryland and operates a busy practice at our outreach center in Carroll County. Dr. Jerome is a fellow of the American College of Cardiology, a fellow of the American Society of Nuclear Cardiology and a fellow of the Society of Cardiovascular Computered Tomography. He is a board member of the Intersocietal Commission for Accreditation of Nuclear Medicine Laboratories. Dr. Jerome has been a primary investigator on multiple clinical research trials and was a member of the technical panel for the Appropriateness Criteria for SPECT Imaging.
Dr. Vasken Dilsizian is Professor of Medicine and Radiology. He heads the section of Nuclear Medicine and is considered to be one of the leading investigators in the field of Nuclear Cardiology and Myocardial Viability. Using various imaging probes, he has published a series of papers that have provided insight into the complex relationship between myocardial perfusion, function, metabolism and leftventricular remodeling in heart failure. He serves as the editor-in-chief of Current Cardiovascular Imaging Reports and associate editor of the JACC - Imaging. He is the co-editor of the Cardiac CT, PET and MRI monograph and the Atlas of Nuclear Cardiology for Braunwald's series of Atlas of Heart Diseases. He is also a co-author of the Nuclear Cardiology chapter in Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.
Dr. Charles White is Professor of Medicine and Radiology and leads the section of Thoracic Radiology. Dr. White has written and lectured extensively on imaging of the heart and great vessels by CT and MR and has pioneered the use of the "triple rule out" CT scan for emergency room patients presenting with chest pain -- a unique method of imaging coronary arteries, pulmonary vasculature, and the aorta in one test. He participates regularly in our Clinical Case Conference.
Dr. Jean Jeudy is an Assistant Professor of Diagnostic Radiology and Nuclear Medicine. In addition to expertise in CT and MR cardiac imaging, Dr. Jeudy has worked assiduously with Dr. Dickfeld in EP to bring anatomy (CT/MR) together with physiology in the form of cardiac PET in a unique form to assist in catheter based complex ablations of ventricular tachycardia.
Dr. David Zimrin trained in Internal Medicine and Cardiology at the University of Pennsylvania. He is the Director of the Cardiac Catheterization Laboratory and Program Director for Interventional Cardiology at the University of Maryland. Dr. Zimrin organizes and runs a weekly cath lab "core" didactic session. His research interests include the use of new circulatory support devices within the cath lab.
Dr. Larry Stafford received his medical degree from Georgetown University and completed Internal Medicine and Cardiology at Rush- Presbyterian Medical Center. Dr. Stafford has extensive clinical expertise in coronary artery disease and intervention, and in the evaluation of the hemodynamics of valvular heart disease. He established and runs a weekly clinical cath lab conference, which is one of the most popular conferences with our fellows.
Dr. Barry Reicher completed an internal medicine residency at Beth Israel Hospital in Boston. He continued his training as a fellow in adult cardiovascular disease and interventional cardiology at the University of Pennsylvania Medical Center. Dr. Reicher has particular interest in percutaneous closure of congenital and acquired septal defects. Dr. Reicher is the Director of the BVAMC Cardiac Catheterization Laboratory.
Dr. Peter Reyes is the Director of Clinical Interventional Cardiology Research. He completed Internal Medicine at MCP/Hahnemann and Cardiology Fellowship at Temple University before coming to University of Maryland for training in Interventional Cardiology. His research interests include novel means of circulatory support, and percutaneous valvular interventions.
Anuj Gupta, M.D., is the Director of Peripheral Interventions. A graduate of the University of Maryland School of Medicine, he trained at Temple University for cardiology and Columbia University for coronary and peripheral interventions. His clinical and educational interests include medical and endovascular management of patients with peripheral arterial disease, AAA, and carotid disease. He heads our efforts towards cath-based peripheral intervention and is currently performing 3-5 of these procedures weekly. Long-term research goals include establishment of a peripheral intervention database, and enrollment of patients into carotid stent trials.
Mark R. Vesely, M.D., F.A.C.C. completed medical school at the George Washington University and post-graduate training (medicine residency, cardiology and interventional cardiology) at the University of Maryland. He participates in the outreach practice at Carroll Hospital Center and attends in the University and VA cath labs. He serves as the associate program director of the Interventional Cardiology fellowship and the associate director of the Carroll Hospital Center Cath lab.
Dr. William Stanley is a Professor of Medicine and Physiology at the University of Maryland and is the Director of Cardiovascular Research. His lab addresses questions regarding the role of substrate metabolism and diet in the pathophysiology of heart failure and acute ischemic events. The lab evaluates cardiac function and metabolic fluxes in vivo, and their effects on the regulation of gene expression, protein function, pathway fluxes and cardiac function and structure. In addition, he studies the basic mechanisms that regulate intermediary metabolism and myocardial energetics. Dr. Stanley organizes a Basic Science Lecture Series for the Division of Cardiology, and will oversee a Translational Science Lecture Series geared towards fellow education.
Dr. Meredith Bond is Professor and Chair of the Department of Physiology in the School of Medicine and holds an adjunct faculty position within the Division of Cardiology. She is an internationally recognized researcher who has focused on Î²-adrenergic pathways in hypertrophied and failing hearts, cardiac function, role of protein kinases, and regulation of phosphorylation of myofibrillar proteins in the heart.
Dr. Steven Liggett is a Professor of Medicine and Physiology and the Director of the Cardiopulmonary Genomics Program. The laboratory has 4 major interrelated sections: 1) the study of the molecular basis of Gprotein coupled receptor structure and function 2) delineation and characterization of human genetic variants within this receptor signaling network 3) association studies of genetic variants with heart and lung disease and their response to treatment (pharmacogenomics) to develop a platform for genetically-based personalized medicine and 4) creation of genetically modified mice to define the mechanisms of heart and lung disease and "humanized mice" to explore the effects of genetic variation of human genes. These studies have lead to new paradigms in our understanding of how this superfamily of receptors (the largest in the human genome) carry out signaling, how they participate in the pathophysiology of congestive heart failure and asthma, and how a patient's genetic makeup can be used to tailor drug treatment.